What is he best known for?
The fields of study he is best known for:
Molecular biology, Cancer research, Pathology, Genetics and Lymphoma are his primary areas of study.
His research in Molecular biology intersects with topics in Cell culture, Bottom-up proteomics, Cytosol, Blot and Regulation of gene expression.
His Cancer research research is multidisciplinary, relying on both Somatic cell, Mutation, Immunology, Chronic lymphocytic leukemia and MAPK/ERK pathway.
In his study, B cell is strongly linked to Immunoglobulin heavy chain, which falls under the umbrella field of Chronic lymphocytic leukemia.
The Immunohistochemistry, Differential diagnosis and Hepatosplenomegaly research Kojo S.J. Elenitoba-Johnson does as part of his general Pathology study is frequently linked to other disciplines of science, such as Thrombocytosis, therefore creating a link between diverse domains of science.
His studies deal with areas such as Perforin, T cell and Germinal center as well as Lymphoma.
His most cited work include:
- ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. (461 citations)
- Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. (341 citations)
- CGG Repeat-Associated Translation Mediates Neurodegeneration in Fragile X Tremor Ataxia Syndrome (297 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Molecular biology, Cancer research, Lymphoma, Pathology and Anaplastic large-cell lymphoma.
The study incorporates disciplines such as Cell culture, Gene expression, Fusion gene, Signal transduction and Polymerase chain reaction in addition to Molecular biology.
His Cancer research research includes elements of Mutation, Immunology, BCL10, breakpoint cluster region and CD20.
His Lymphoma study integrates concerns from other disciplines, such as Proteomics, Germinal center and Gene expression profiling.
Kojo S.J. Elenitoba-Johnson has included themes like Leukemia and Immunophenotyping in his Pathology study.
His research integrates issues of Tyrosine kinase and CD30 in his study of Anaplastic large-cell lymphoma.
He most often published in these fields:
- Molecular biology (41.47%)
- Cancer research (27.52%)
- Lymphoma (25.97%)
What were the highlights of his more recent work (between 2015-2020)?
- Cancer research (27.52%)
- Lymphoma (25.97%)
- Pathology (17.05%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Lymphoma, Pathology, Cancer and Cell biology.
His work on Lymphomatoid papulosis as part of general Cancer research study is frequently linked to Tyrosine kinase 2, therefore connecting diverse disciplines of science.
The Lymphoma study combines topics in areas such as Precision medicine, MALT1, Gene expression profiling, T cell and B cell.
His work focuses on many connections between T cell and other disciplines, such as Stromal cell, that overlap with his field of interest in Immunology.
His Pathology research incorporates themes from Carcinogenesis and Erythrocyte sedimentation rate.
His Cell biology research is multidisciplinary, incorporating perspectives in Biogenesis and Cell growth.
Between 2015 and 2020, his most popular works were:
- International, evidence-based consensus diagnostic criteria for HHV-8–negative/idiopathic multicentric Castleman disease (150 citations)
- Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer. (115 citations)
- International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease (76 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Cancer research, Pathology, Epigenetics, Histone and Gene expression profiling.
The various areas that Kojo S.J. Elenitoba-Johnson examines in his Cancer research study include Cancer, Proteogenomics, Precision medicine and Lymphoma.
His Cancer research includes themes of Molecular biology, Decoy and Ubiquitin ligase.
His work in the fields of Lymphoma, such as Anaplastic large-cell lymphoma, overlaps with other areas such as Anaplastic Lymphoma.
His work carried out in the field of Pathology brings together such families of science as Carcinogenesis, KRAS and Germline.
His Gene expression profiling research incorporates elements of Regulation of gene expression and RHOA.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
